FENNEC PHARMACEUTICALS INC. (FENC) › Shareholders' EquityFENNEC PHARMACEUTICALS INC. (FENC) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.1996: $01997: -$37.0K1998: -$435.0K1999: $242.0K2000: $47.0K2001: $9.79M2002: $6.07M2003: $698.0K2004: $16.65M2005: $11.08M2006: $1.27M2007: $14.15M2008: $3.05M2009: $406.0K2010: -$4.92M2011: -$119.0K2012: -$4.96M2013: -$1.46M2014: $613.0K2015: $548.0K2016: $3.57M2017: $26.76M2018: $21.31M2019: $11.88M2020: $29.07M2021: $15.77M2022: -$2.57M2023: -$11.62M2024: -$5.87M2025: $35.47M$35.47M1996Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$35.47M+704.1%2024-$5.87M+49.5%2023-$11.62M-352.4%2022-$2.57M-116.3%2021$15.77M-45.7%2020$29.07M+144.8%2019$11.88M-44.3%2018$21.31M-20.3%2017$26.76M+649.5%2016$3.57M+551.5%2015$548.0K-10.6%2014$613.0K+142.1%2013-$1.46M+70.6%2012-$4.96M-4065.5%2011-$119.0K+97.6%2010-$4.92M-1313.1%2009$406.0K-86.7%2008$3.05M-78.4%2007$14.15M+1015.8%2006$1.27M-88.6%2005$11.08M-33.5%2004$16.65M+2286.0%2003$698.0K-88.5%2002$6.07M-38.0%2001$9.79M+20734.0%2000$47.0K-80.6%1999$242.0K+155.6%1998-$435.0K-1075.7%1997-$37.0K—1996$0—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share